<PAGE>
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
Date of Report: January 16, 2001
VISION-SCIENCES, INC.
------------------------------------------------------
(Exact Name of Registrant as Specified in its Charter)
DELAWARE
----------------------------------------------
(State or Other Jurisdiction of Incorporation)
0-20970 13-3430173
------------------------ ------------------------------------
(Commission File Number) (I.R.S. Employer Identification No.)
9 STRATHMORE ROAD, NATICK, MA 01760
-------------------------------------------------------------------------------
(Address of Principal Executive Offices) (Zip Code)
(508) 650-9971
----------------------------------------------------
(Registrant's Telephone Number, Including Area Code)
NOT APPLICABLE
-------------------------------------------------------------
(Former Name or Former Address, if Changed Since Last Report)
<PAGE>
ITEM 5. OTHER EVENTS
Vision-Sciences, Inc., (the "Company") announced on January 3, 2001
that the Company has completed a $3,464,200 private equity placement with Mr.
Katsumi Oneda, Chairman, CEO and President, Mr. Lewis Pell, Vice Chairman, Dr.
Gerald B. Lichtenberger, Vice President of Business Development, Mr. Kenneth
Anstey, a member of the Company's Board of Directors and a group of private
investors. The Company sold an aggregate of 5,587,418 shares of common stock at
a price of $0.62 per share, which represents 80% of the average closing price of
the common stock during the five trading days ended December 11, 2000. A copy of
the Company's press release regarding the transaction is attached hereto as
Exhibit 99.1.
ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS
(c) Exhibits
EXHIBIT NO. EXHIBIT
99.1 Press release, dated January 3, 2001, announcing $3.5 million
private placement.
<PAGE>
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
Date: January 16, 2001 VISION-SCIENCES, INC.
By: /s/ James A. Tracy
----------------------
James A. Tracy
Vice President Finance, Chief Financial and
Accounting Officer